Protalix Biotherapeutics, Inc. (PLX)
2.165
0.00 (0.00%)
USD |
NYAM |
Mar 26, 15:02
Protalix Biotherapeutics Cash from Investing (Quarterly) : -1.112M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 20.77M |
| Agenus, Inc. | 0.78M |
| Lisata Therapeutics, Inc. | 0.00 |
| InspireMD, Inc. | -45.14M |
| Lifeward Ltd. | -0.011M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.03M |
| Cash from Financing (Quarterly) | 0.146M |
| Free Cash Flow | -13.63M |
| Free Cash Flow Per Share (Quarterly) | 0.0202 |
| Free Cash Flow to Equity (Quarterly) | 1.483M |
| Free Cash Flow to Firm (Quarterly) | 2.068M |
| Free Cash Flow Yield | -7.89% |